Navigation Links
Birds going extinct faster due to human activities

Embryonic stem cells, prized for their astonishing ability to apparently transform into any kind of cell in the body, acquire their identities in part by interacting with their surroundings - even when they are outside of the body in a laboratory dish, University of Florida scientists report.

Using an animal model of embryonic stem cell development, researchers with UF's McKnight Brain Institute have begun to answer one of the most fundamental questions in science - how does a batch of immature cells give rise to an organ as extraordinarily complex as the human brain?

The findings, to be published this week in the Proceedings of the National Academy of Sciences, may one day help scientists create laboratory environments to grow specialized cells that can be transplanted into patients to treat epilepsy, Parkinson's, Huntington's and Alzheimer's diseases or other brain disorders.

Scientists observed that when embryonic stem cells from mice were plated on four different surfaces in cell culture dishes, specific types of cells would arise.

"The medium and the molecular environment influence the fate of the cell," said Dennis Steindler, Ph.D., executive director of the McKnight Brain Institute. "We simulated some events that occur while the brain is developing and challenged them with different environments, and the effects are profound. Ultimately both nature and nurture influence the final identity of a stem cell, but in early stages it seems nurture is very important."

In experiments, scientists confirmed a cell culture surface molecule called laminin activates a common developmental pathway that is crucial for the generation and survival of particular types of brain cells.

The laminin-influenced stem cells are a kind that goes on to generate a brain structure called the medial ganglionic eminence, which in turn is believed to give rise to a population of early neurons in the developing cerebral
'"/>

Source:Missouri Botanical Garden


Page: 1 2 3

Related biology news :

1. Birds brains reveal source of songs
2. Birds and bats sow tropical seeds
3. Birds that make teeth
4. Birds found to plan for the future
5. Mayan stingless bee keeping: Going, going, gone?
6. The shape of things to come: Morphology database going global
7. Watch your step when the going gets rough
8. When the going gets tough, slime molds start synthesizing
9. EGF receptor activation prevents microbes from going more than skin deep
10. Ongoing collapse of coral reef shark populations
11. Low level of extinction during ice age linked to adaptability

Post Your Comments:
(Date:11/19/2009)...Tenn., Nov. 19, 2009 -- Sustainable farming, initi...enerations, may also play a role in maintaining a ...epartment of Energy,s Oak Ridge and Los Alamos nat...re exploring the large potential of the earth,s so...hat new land-use practices could greatly reduce U....
(Date:11/19/2009)...TTE, Ind. - Purdue University scientists have help...onsible for cell wall development in maize, an eff... produce the biomass best suited for biofuels prod... Carpita, a professor of plant cell biology, publi...the journal Plant Physiology on Thursday (Nov. 1...
(Date:11/19/2009)...ler, University of Cincinnati professor of paleont...and co-author Michael Foote of the University of C... of Science with their paper, "Epicontinental Se...s Extinction and Origination." , For many years,...tory of biodiversity have focused on charting the ...
Breaking Biology News(10 mins):ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Maize cell wall genes identified, giving boost to biofuel research 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 2Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 3Paleontologists find extinction rates higher in open-ocean settings during mass extinctions 4Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 1Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 2Quark Pharmaceuticals to Present Data on its siRNA Therapeutic Programs in Kidney and Lung Diseases 5908 3Prasco Enters into Agreements with sanofi aventis U S to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Wi 5904 1Prasco Enters into Agreements with sanofi aventis U S to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Wi 5904 2Lops named Life Care 26apos 3Bs New Chief Compliance Officer 60510 1Lops named Life Care 26apos 3Bs New Chief Compliance Officer 60510 2
...bacteria can use a Sonar-like system to spot other...) and target them for destruction.,Reported in the...ns how,some bacteria know when to produce a toxin ...he design of new toxin inhibitors. “Blocking or,in... should prevent,toxin production and limit the sev...
...important role in the development of prostate canc...niversity School of Medicine and the,University of...line,this week in the Proceedings of the National ...ch is separate from nuclear DNA, is found,in the h...utside of,each cell,s nucleus. The mitochondria of...
... "A Method of Reconstituting Nucleic Acid Molecule...ixDesign, and CEO of DermaPlus, Inc. The patent co...es from "degraded" DNA samples, and could allow sc..., extinct animals to unsolved crime scenes. , "Thi...ts, brings us closer to our goal of reconstructing...
Other Biology News:Antibiotic Resistant Bacterium Uses Sonar-like Strategy to “See?Enemies or Prey 2Mitochondrial DNA mutations play significant role in prostate cancer 2Dinosaur DNA? New Patent Covers Degraded DNA recovery 2
(Date:11/19/2009)...Newswire-FirstCall/ -- Omeros Corporation (Nasdaq:...ts for the third quarter ended September 30, 2009....eros reported a net loss of $3.9 million, or $1.34...ion, or $2.54 per share, for the same period in 20...the Company reported a net loss of $15.5 million, ...
(Date:11/19/2009)...RNewswire-FirstCall/ -- NeoStem, Inc. (NYSE Amex: ...wing letter to its shareholders, discussing the Co... Biopharmaceuticals Holdings, Inc. (CHBP), an inte...ple,s Republic of China. The merger gives NeoStem ...utical Co. Ltd., CHBP,s primary operating subsidia...
(Date:11/19/2009)...any, November 19 MONITORING FORCE ...th, 2009 Flibanserin in the,indication treatment-r...,disease for orphan drug status designation with t...ced dyskinesia is a complication of the mainstay,t...den to some of those,affected, since it may be dis...
(Date:11/19/2009)...,s Top Gene Synthesis Companies Form International...st Practices in Risk Reduction ,Five Member Comp...esis Capacity , (PRWEB) N...ing gene synthesis companies today announced agree...col to promote biosecurity in the gene synthesis i...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4
..., BENICIA, Calif., March 3 AcroMetrix, a leading ...s and controls for clinical diagnostic and blood t...f the OptiQuant-S HCV RNA Quantification Panel. T...nTura(TM) Technology and provides laboratories wit...itis C molecular assays available in today,s marke...
..., SAN DIEGO, March 2 BioMed Realty Trust, Inc. (N...xecutive management will present at the Citi 2009 ...at approximately 9:05 a.m. Eastern Standard Time o...will be open to all investors by calling 719.785.5... BioMed Realty Trust , BioMed Realty Trust, Inc. ...
..., Merger provides additional value to clients, sha...ASG, Inc. - a high-quality functional outsourcing ...y, North Carolina - has acquired neighboring Ockha... research organization. , , The acquisition - co...t of stock - enables ASG to expand the breadth and...
Other Biology Technology:AcroMetrix Announces the Release of OptiQuant-S Hepatitis C Virus (HCV) Panel 2Clinical Research Staffing Firm ASG Acquires CRO Ockham Development Group 2
... Point Osmometer for 10 L sample. Ideal for small...l, geriatric, general adult, veterinary and experi... user-selected values. Includes built-in printer,...record-keeping. Optional barcode scanner availabl...
SMD1168 from Invitrogen
Human Atherosclerosis Antibody Array 1.1 (4) Kit, RayBio from Raybiotech, Inc.
Catch and Release® v2.0
Reversible Immunoprecipitation System from Upstate
Biology Products: